GlaxoSmith C H L

Sebi enacts significant changes to disclosure and RPT regulations

FPIs return to equities; infuse Rs 22,766 cr in first two weeks of Dec

Mcap of 5 of top-10 most valued firms climb to Rs 1.13 trn; Airtel shines

Mkts to be guided by US Fed rate decision, WPI inflation, trends: Analysts

Eleganz Interiors files draft papers with NSE Emerge to raise funds via IPO

Please take the context from the pdf file as it is more than 1000 word context

Dear Sir / Madam<BR> Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Regulations) we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders:<BR> Sr.no. Name Folio no. Certificate no. No. of Shares Dist From Dist To<BR> 1. Pravin Chandra Chunilal Kothari P01213 107649 50 13250227 13250276<BR> <BR> We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company.<BR> Kindly take the same on record.<BR>

Pursuant to Reg 39 of SEBI (LODR) Regulations 2015 (the Regulations) we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders:<BR> Sr.no. Name Folio no. Certificate no. No. of Shares Dist From Dist To<BR> 1. Anand Ram Raitani<BR> A03726<BR> 119137<BR> 193009<BR> 284334<BR> 284335 160 14114885<BR> 14442086<BR> 28658595<BR> 28658645 14114934<BR> 14442135<BR> 28658644<BR> 28658654<BR> 2. Gurmehar Singh Majithia<BR> G01509<BR> 136067<BR> 203176<BR> 355426 - <BR> 355439 1776 12511082<BR> 25272645<BR> 41754594 12511111<BR> 25273724<BR> 41755259<BR> 3. Mallappa Dodakallappa Hangarki Sharada C Yashoda Hangarki<BR> M00546 14492<BR> 40510<BR> 67528<BR> 103070 100 539046<BR> 4807839<BR> 6735201<BR> 12980610 539070<BR> 4807850<BR> 6735213<BR> 12980659<BR> <BR> We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company<BR>

Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Regulations) we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders:<BR> Sr.no. Name Folio no. Certificate no. No. of Shares Dist From Dist To<BR> 1. Kantalaxmi S Shah K04208<BR> 134813 25 4923657<BR> 6852362 4923668<BR> 6852374<BR> 2. Kantalaxmi Shantilal Shah<BR> Shantilal Durlabhdas Shah K00804<BR> 65683<BR> 121427 18 6671486<BR> 12752038 6671494<BR> 12752046<BR> <BR> We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company<BR> Kindly take the same on record.<BR>

Pursuant to Reg 30(7) of SEBI LODR further to our communication dated Feb 26 2020 plS see enclosed a copy of the order dated Feb 26 2020 and clarification dated Feb 28 2020 alongwith order as per Form CAA 7 issued by the Honble (NCLT) Chandigarh Bench on March 12 2020 in respect of the scheme of amalgamation amongst GlaxoSmithKline Consumer Healthcare Limited and HUL and their respective shareholders and creditors under Section 230 to 232 of the Companies Act 2013 (Scheme). <BR> In this regard we wish to inform you that in accordance with the terms of the Scheme a meeting of Board of Director of the Company is scheduled to be held on Wednesday April 01 2020 to take on record the sanction of the Scheme by Honble NCLT Mumbai Bench and Chandigarh Bench and to declare the scheme effective. <BR> Further it is to inform you that at this BM will consider the record date for the purpose of issuance of shares of HUL to the shareholders of the Company in accordance with the Scheme.<BR>